Key result
A tissue-engineered auto-xenograft pulmonary heart valve showed no cusp calcification at 100 days in sheep, and a similarly prepared allograft valve showed excellent short-term safety in 6 patients.
Why the study?
Does a tissue-engineered auto-xenograft pulmonary heart valve resist calcification and demonstrate safety in juvenile sheep and human patients?
Does a tissue-engineered auto-xenograft pulmonary heart valve resist calcification and demonstrate safety in juvenile sheep and human patients?
A tissue-engineered auto-xenograft pulmonary valve demonstrated resistance to calcification in a sheep model and initial safety in a small human cohort, suggesting potential for improved durability of stentless valves.
Answers are grounded in this paper and cite their sources.
May support further development of tissue-engineered valves; leaves open long-term durability and safety in larger human trials.
To improve the durability of stentless valves without losing their excellent hemodynamic function, a new-generation auto-xenograft was developed and evaluated. A piece of vein was harvested from 3 juvenile sheep 6 weeks before implantation of the valve. Endothelial cells from the vein material were cultivated and used to reendothelialize a decellularized porcine pulmonary valve. The tissue-engineered valve was implanted into the right ventricular outflow tract of the juvenile sheep. It was explanted after 100 days and assessed macroscopically as well as by x-ray, light microscopy (hematoxylin and eosin staining and von Kossa staining), and scanning electron microscopy. Calcium content of the cusps was determined quantitatively by atomic absorption spectrometry. The sheep implanted with the valve recovered quickly without any problems during the observation period. X-ray examination of the 3 explanted valves showed no cusp calcification, which was confirmed by histological study. Atomic absorption spectrometry showed low tissue calcium content. A clinical safety and feasibility trial with an allograft valve prepared the same way showed excellent short-term results in 6 patients.
No takes yet. Share an insight, caveat, or question.
Dohmen et al. (2002) studied Heart valve replacement (n=9). Tissue-engineered auto-xenograft/allograft pulmonary heart valve was evaluated on Valve calcification and clinical safety/feasibility. A tissue-engineered auto-xenograft pulmonary heart valve showed no cusp calcification at 100 days in sheep, and a similarly prepared allograft valve showed excellent short-term safety in 6 patients.
Synapse has enriched 10 related papers. Consider them for comparative context: